Now that my tenure as Solve M.E. President and CEO has ended, I’m pleased to introduce you to new Interim CEO, Maryellen Gleason.
Maryellen Gleason has been with Solve M.E. for several months in our senior development role and is now stepping in as Interim CEO. She has served in the CEO role for several non-profits, and specializes in leading organizations during transition where significant growth is desired. She understands our work and has internalized our passion for solving this disease.
Get to know her in the video below:
I feel confident that I’m leaving Solve M.E. in capable and vigorous hands with Maryellen at the helm. I’ll sustain my commitment to ME/CFS with my work as a Solve M.E. board member. Our national executive search firm continues its work to identify our new permanent CEO.
Our Chief Scientific Officer, Dr. Sadie Whittaker, our Director of Advocacy and Community Relations, Emily Taylor, and the entire Solve M.E. staff bring their experience to this transition as their forward work continues unabated.
Onward, with real hope!
Carol Head
Solve M.E. board member